Litcius/Paper detail

MRI of the joint and evaluation of the granulocyte–macrophage colony-stimulating factor–CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study

Mark C. Genovese, Mario Berkowitz, Philip G. Conaghan, Charles Peterfy, Katherine Davy, Elena Fisheleva, Anubha Gupta, David R. Inman, Robert L. Janiczek, Mark Layton, Nina Mitchell, Jatin Patel, Alexandra H. Roberts, Didier Saurigny, Julia E. Smith, R. Williamson, Paul P. Tak

2020The Lancet Rheumatology27 citationsDOI

Topics & Concepts

MedicineRheumatoid arthritisInternal medicinePlaceboRheumatologyRheumatismClinical endpointArthritisRheumatoid factorPhysical therapyClinical trialSurgeryPathologyAlternative medicineRheumatoid Arthritis Research and TherapiesMultiple Sclerosis Research StudiesSpondyloarthritis Studies and Treatments
MRI of the joint and evaluation of the granulocyte–macrophage colony-stimulating factor–CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study | Litcius